Complete response of advanced hepatocellular carcinoma to sorafenib: another case and a comprehensive review

Complete response of advanced hepatocellular carcinoma to sorafenib: another case and a comprehensive review

Since sorafenib was introduced in 2007 for treating advanced hepatocellular carcinoma (HCC), 15 patients have achieved a complete response (CR) in advanced HCC. However, only four of these reports can be regarded as real CRs involving adequate assessments including imaging, serum tumor markers, and...

Full description

Bibliographic Details
Main Authors: Tae Suk Kim, Ji Hoon Kim, Baek hui Kim, Young-Sun Lee, Yang Jae Yoo, Seong Hee Kang, Sang-June Suh, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2017-12-01
Series:Clinical and Molecular Hepatology
Subjects:
Hepatocellular carcinoma
Sorafenib
Response evaluation criteria in solid tumors
Hepatitis C
Online Access:http://e-cmh.org/upload/pdf/cmh-2016-0070.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-2016-0070.pdf

Similar Items